Closing Bell: Cardiol Therapeutics Inc down on Friday (CRDL)

In trading today, Cardiol Therapeutics Inc shares opened at $2.83 and closed at $2.73. Intraday prices ranged from a low of $2.70 to a high of $2.85.

The price eased -5.86% from the previous day's close of $2.90.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.

Cardiol Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker CRDL.

A total of 128,429 shares was traded during the session, with total trades of 386. On average, Cardiol Therapeutics Inc has traded 90,042 shares over 5 days and 148,802 year-to-date.

The TSX market on the whole today saw 741 price advancers against 4,512 declines and 69 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, in the last 12 months, Cardiol Therapeutics Inc's shares have soared 89.58%, while they have risen 148.18% this year.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $201.24 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Cardiol Therapeutics Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..